Mirador Therapeutics
Develops next-generation therapies for immune-mediated inflammatory and fibrotic diseases
$250MSeries B
Role not disclosedMS
Moore Strategic Ventures
Activity from announced rounds
Activity in this selectionJan 31, 2026 · Jan 1, 2026
Moore Strategic Ventures is the investor explicitly identified by CADDi and Mirador issuer announcements.
Recorded funding activity
CADDi structures manufacturing data. Other recorded activity includes Slice’s consumer banking and Sierra Space’s infrastructure and defence systems. The firm remains distinct from Louis Bacon personally and other Moore entities.
Sources
- Rounds participated in
- 1
- Confirmed lead rounds
- — 1 roles undisclosed
- New companies
- 1 First participation on record · 0 follow-on
- Funding in participating rounds
- $250M 1 disclosed · full round size, not this investor’s share